117 related articles for article (PubMed ID: 7177276)
1. Altered prednisolone kinetics in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Nephron; 1982; 32(1):45-8. PubMed ID: 7177276
[TBL] [Abstract][Full Text] [Related]
2. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
[TBL] [Abstract][Full Text] [Related]
3. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures.
Frey BM; Frey FJ
J Clin Endocrinol Metab; 1985 Feb; 60(2):361-9. PubMed ID: 3155524
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
[TBL] [Abstract][Full Text] [Related]
5. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
[TBL] [Abstract][Full Text] [Related]
6. Prednisolone disposition and protein binding in oral contraceptive users.
Boekenoogen SJ; Szefler SJ; Jusko WJ
J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
Frey BM; Schaad HJ; Frey FJ
Eur J Clin Pharmacol; 1984; 26(4):505-11. PubMed ID: 6734709
[TBL] [Abstract][Full Text] [Related]
9. The separation of unbound prednisolone in plasma by centrifugal ultrafiltration.
Miller PF; Wheeldon J; Brocklebank JT
J Pharm Pharmacol; 1987 Nov; 39(11):939-41. PubMed ID: 2892921
[TBL] [Abstract][Full Text] [Related]
10. Prednisolone binding to albumin and transcortin in the presence of cortisol.
Rocci ML; D'Ambrosio R; Johnson NF; Jusko WJ
Biochem Pharmacol; 1982 Feb; 31(3):289-92. PubMed ID: 7073761
[TBL] [Abstract][Full Text] [Related]
11. The serum concentrations of unbound, transcortin bound and albumin bound cortisol in patients with dysproteinemia.
Yamamoto M; Ariyoshi Y; Matsui N
Endocrinol Jpn; 1982 Oct; 29(5):639-46. PubMed ID: 7182182
[TBL] [Abstract][Full Text] [Related]
12. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
Frey FJ; Rüegsegger MK; Frey BM
Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of prednisolone in children with the nephrotic syndrome.
Rostin M; Barthe P; Houin G; Alvinerie M; Bouissou F
Pediatr Nephrol; 1990 Sep; 4(5):470-3. PubMed ID: 2242307
[TBL] [Abstract][Full Text] [Related]
14. Prednisone side-effects and serum-protein levels. A collaborative study.
Lewis GP; Jusko WJ; Graves L; Burke CW
Lancet; 1971 Oct; 2(7728):778-80. PubMed ID: 4106604
[No Abstract] [Full Text] [Related]
15. Binding of prednisolone to alpha 1-acid glycoprotein.
Milsap RL; Jusko WJ
J Steroid Biochem; 1983 Feb; 18(2):191-4. PubMed ID: 6843123
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone clearance at steady state in man.
Legler UF; Frey FJ; Benet LZ
J Clin Endocrinol Metab; 1982 Oct; 55(4):762-7. PubMed ID: 7107818
[TBL] [Abstract][Full Text] [Related]
17. Drug protein binding and the nephrotic syndrome.
Gugler R; Azarnoff DL
Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
[TBL] [Abstract][Full Text] [Related]
18. Endogenous and exogenous glucocorticoids in cushingoid patients.
Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
[TBL] [Abstract][Full Text] [Related]
19. Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion.
Frey BM; Frey FJ
Br J Clin Pharmacol; 1982 Feb; 13(2):245-9. PubMed ID: 6800390
[No Abstract] [Full Text] [Related]
20. [The metabolism of hydrocortisone, prednisolone and fluocortolone (author's transl)].
Gleispach H; Porta S
Wien Klin Wochenschr; 1981 Nov; 93(21):671-3. PubMed ID: 7324480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
